HIV

Bristol Myers settles anti-generic HIV drug scheme allegations for almost $11M
Endpoints
Wed, 06/8/22 - 10:18 am
Bristol Myers Squibb
legal
HIV
generics
competition
California
Gilead HIV prospect escapes FDA hold after glass compatibility glitch triggered regulatory setbacks
Fierce Pharma
Tue, 05/17/22 - 10:34 am
Gilead Sciences
drug manufacturing
FDA
HIV
lenacapavir
Is Gilead Sciences Too Dependent On These 2 Areas of Its Business?
Motley Fool
Sun, 05/8/22 - 12:17 pm
Gilead Sciences
COVID-19
Veklury
earnings
HIV
'Who wants to make money?' Court documents outline wild fraud scheme targeting Gilead HIV meds
Fierce Pharma
Fri, 05/6/22 - 10:46 am
Gilead Sciences
legal
fraud
HIV
PrEP
J&J files lawsuit against several pharmacies and distributors over counterfeit HIV medication
Endpoints
Wed, 04/27/22 - 10:36 pm
JNJ
HIV
drug counterfeiting
Gilead presses HIV drug fraud in court, wins freeze of 'kingpin' assets
Fierce Pharma
Wed, 04/20/22 - 10:56 am
Gilead Sciences
fraud
HIV
PrEP
Truvada
Descovy
Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court
Fierce Pharma
Fri, 04/15/22 - 01:54 pm
JNJ
Bristol Myers Squibb
Gilead Sciences
HIV
legal
anticompetitive practices
generics
Physician poll finds ultralong-acting regimens and home administration could transform HIV market
Fierce Pharma
Tue, 04/5/22 - 11:02 am
HIV
physicians
GSK
Gilead Sciences
ViiV Healthcare
After FDA hold, CytoDyn will appeal for pharma partnerships to save leronlimab
Fierce Biotech
Thu, 03/31/22 - 10:39 am
CytoDyn
FDA
clinical holds
HIV
leronlimab
With competitors circling, ViiV wins another label update for long-acting HIV injectable Cabenuva
Endpoints
Thu, 03/24/22 - 08:33 pm
ViiV Healthcare
GSK
FDA
Cabenuva
HIV
Janssen
Moderna hits the gas as it begins dosing of 2nd HIV vaccine
Fierce Biotech
Mon, 03/14/22 - 11:40 pm
Moderna Therapeutics
MRNA
HIV
vaccines
clinical trials
Bottlenecks are slowing switch to GSK's long-acting HIV injectable Cabenuva: clinician
Fierce Pharma
Tue, 03/8/22 - 10:57 pm
GSK
HIV
Cabenuva
supply chain
distribution
FDA rejects Gilead's closely watched HIV drug
BioPharma Dive
Tue, 03/1/22 - 10:05 pm
Gilead Sciences
HIV
FDA
lenacapavir
GSK to get $1.25 bln to settle HIV drug patent row with Gilead
Reuters
Wed, 02/2/22 - 11:01 am
GSK
Gilead Sciences
HIV
Biktarvy
patents
ViiV Healthcare gets FDA nod for two-month dosing of Cabenuva to treat HIV
Pharmaceutical Business Review
Wed, 02/2/22 - 10:57 am
ViiV Healthcare
FDA
HIV
Cabenuva
Blockbuster cancer med Keytruda may help flush out dormant HIV, suggesting a new way to treat long-running epidemic
Fierce Biotech
Thu, 01/27/22 - 11:38 pm
HIV
Merck
Keytruda
Vir expands partnership with Gates Foundation, adding $50M for HIV and malaria antibody research initiative
Endpoints
Sun, 01/16/22 - 03:50 am
Vir Biotechnology
vaccines
Gates Foundation
HIV
malaria
FDA slaps a hold on Gilead's injectable HIV treatment over concerns about potential glass contaminants
Endpoints
Wed, 12/22/21 - 11:01 am
Gilead Sciences
FDA
HIV
lenacapavir
clinical trials
clinical hold
FDA clears first long-acting HIV-prevention injectable, giving ViiV claim to historic OK
Endpoints
Tue, 12/21/21 - 10:24 am
FDA
HIV
PrEP
Apretude
GSK
ViiV Healthcare
Digital pill tracks HIV PrEP adherence with 98% accuracy
Pharmaforum
Thu, 12/9/21 - 10:38 am
digital pills
HIV
PrEP
Gilead Sciences

Pages